全球止血器械市場：市場規模、佔有率和趨勢分析（2026-2032 年）

2025年全球止血設備市場規模約7.16億美元。預計到2032年，該市場規模將達到約9.45億美元，年複合成長率為4.0%。

本報告涵蓋止血探針、結紮器械、硬化治療針和止血粉，這些產品共同構成了完整的全球止血器械市場。報告量化了銷售量、平均售價、市場價值、成長率和企業市場占有率。此外，報告還分析了市場趨勢和促進因素、近期併購活動以及技術發展。報告提供了2022年至2024年的歷史數據以及至2032年的預測數據。

它反映了醫院和內視鏡中心如何評估產品性能、聯合治療和設備創新，以改善治療效果並有效控制消化道出血。

市場概覽

止血器械用於控制和預防胃腸道手術過程中的出血。這些器械包括止血探針、血管夾和結紮帶、硬化治療針和止血粉。這些器械對於治療急性出血、預防術後併發症以及減少手術介入的需求至關重要。

隨著患者族群結構和手術趨勢的變化，全球市場持續擴張。人口老化以及肝硬化、肝炎和消化性潰瘍等疾病盛行率的上升，推動了止血干預措施的需求。消化道出血發生率的增加，促使醫療專業人員採用各種止血解決方案，以提高安全性並縮短手術時間。

影響該市場的最重要發展之一是聯合治療的興起。研究表明，將硬化針與血管夾或電外科探針相結合的治療方法成功率高，並能減少再次手術的需求。隨著醫生和患者都尋求更有效率的治療方法和更少的復發，這些聯合治療的應用正在增加。

儘管價格壓力和採購動態將繼續給製造商帶來課題，但手術量的增加、全球市場的擴大以及持續的技術進步預計將維持到 2032 年的長期成長。

市場促進因素

聯合治療

聯合治療，即硬化針與其他止血器械（如血管夾或電外科探針）聯合使用，已被證明比單一器械治療更有效。這些療法透過提高止血成功率並減少後續治療需求，增強了醫生的信心並改善了患者的治療效果。

這種方法不僅提高了臨床應用率，也增加了每次手術的設備消費量。隨著醫院向實證醫療模式轉型，對多設備解決方案的偏好將繼續推動設備消耗量的成長。

血管夾

隨著越來越多醫生傾向於使用結紮夾而非結紮來控制出血和閉合的黏膜缺損，結紮夾市場呈現穩定成長的態勢。結紮夾通常在每次手術中多次使用，增加了結紮夾的總量。此外，與結紮帶相比，結紮夾產品的價格更高，這也推動了市場價值的成長。

夾子設計和展開系統的持續產品創新進一步鞏固了這個領域。精確度更高、旋轉控制更精準、展開更可靠的設備提高了臨床效率和使用者信心。

人口統計因素

人口老化仍然是止血設備市場最強勁的宏觀經濟促進因素之一，因為老年人由於慢性肝病、靜脈曲張以及其他增加出血風險的合併症，消化道出血的發生率更高。

同時，不良的生活方式，例如飲食不健康、飲酒和非類固醇消炎劑的使用，正在增加消化道出血的發生率，即使在年輕人中也是如此。這些人口統計和行為因素的綜合影響預計將使相關手術需求保持高位，並推動市場在2032年之前持續擴張。

提高內視鏡能力

內視鏡技術的進步使醫生無需手術即可治療多種出血性疾病。現代內視鏡系統能夠精確顯示出血部位，而對電外科能量的更精準控制則有助於更快地凝血。這些優勢提高了手術成功率，並促進了止血產品在醫院和門診中心的利用。

市場限制

集團採購組織（GPO）

集團採購組織（GPO）是醫院設備的主要採購管道，但同時也限制了市場成長。 GPO匯集需求並協商批量價格，限制了製造商維持較高平均售價的能力。

此外，過度依賴標準化採購協議會限制醫院取得新產品或特色產品的機會。嚴重依賴集團採購組織（GPO）合約的供應商可能會面臨價格實現速度較慢以及在簽約機構內擴展產品系列的靈活性降低的問題。

替代療法

藥廠持續研發預防意外消化道出血的藥物。這些療法，特別是那些針對抗凝血逆轉和潰瘍保護的療法，可能會降低需要手術干預的出血發生率。

這些藥物的廣泛應用可能會減少手術量，在某些情況下，會減緩對機械和電外科止血設備的需求。

市場競食

在更廣泛的止血市場中，不同設備類型之間的競爭限制了整體價值成長，例如，結紮夾雖然迅速擴張，但市場佔有率卻被電外科探針、熱探針和氬等離子體凝固探針蠶食。

這些裝置也可與夾子搭配使用，但與硬化療法針頭搭配使用效果最佳。隨著產品偏好的變化，某一類別的成長可能會以犧牲其他類別的成長為代價，導致市場內部格局的轉變，而非淨成長。

目標市場和數據範圍

定量範圍

市場規模、市佔率、市場預測、成長率、銷售量、平均售價

定性範圍

成長趨勢、限制因素、競爭分析及競爭對手SWOT分析、併購、公司概況及產品系列、FDA召回事件、顛覆性技術、影響止血設備需求的疾病概述

時期

基準年為2025年，預測期間為2026-2032年，歷史資料為2022-2024年。

數據來源

對內視鏡醫師、採購經理和行業高管的初步調查、醫院採購和監管資料庫、進出口資料以及iData Research內部資料庫

方法注記

收入預測模型為銷售量乘以平均售價，並根據每種設備類型的手術量和使用率假設檢驗。

目標市場及區隔

• 止血器械市場進一步區隔為：

止血探針

結紮裝置

硬化治療針

止血粉

競爭分析

2025年，波士頓科學公司是全球止血器械市場的領導者，在所有主要區隔市場中保持著強勁的地位。該公司在血管夾市場的領先地位，得益於2016年推出的Resolution 360™以及2020年Resolution 360™ ULTRA的升級。波士頓科學公司也銷售其旗艦止血探針產品線－Gold Probe™系列，該系列產品以其穩定的性能和可靠性而廣受認可。

奧林巴斯公司憑藉其豐富的產品系列和在胃腸內視鏡領域長期累積的專業技術，位居市場第二。其在結紮器材領域的領先地位也鞏固了其競爭優勢。此外，奧林巴斯仍是熱探針的唯一供應商，其HeatProbes™產品線在全球廣泛應用於內視鏡熱凝治療。

庫克醫療在止血器材市場佔有第三大佔有率。該公司的主打產品是6 Shooter® Universal Saeed®多功能結紮器，該產品廣泛應用於內視鏡結紮手術。此外，該公司還生產血管夾、電外科探針和硬化治療針，為多種內視鏡應用提供全面的產品組合。

競爭格局集中度適中，前三大企業佔了大部分市場佔有率。區域性參與企業主要服務於對成本較為敏感的市場，定價彈性和本地分銷關係是它們的優勢所在。

科技與臨床趨勢

聯合治療方案正逐漸成為治療消化道出血的標準方法，從而提高了治療成功率並降低了再次出血的風險。

一次性醫療設備的使用日益普及，尤其是在醫院等對感染控制和工作流程效率要求較高的場所。

改進的夾子和探針設計提高了手術精度、旋轉控制和放置一致性。

能量型止血技術，如熱探針和氬等離子體凝固術，仍是與機械儀器結合使用的重要工具。

隨著培訓的擴展和指南的製定，醫生們對多器械止血技術越來越熟悉。

粉狀止血劑作為瀰漫性出血部位和難以觸及部位的輔助治療手段，引起了人們的興趣。

這些趨勢顯示市場正在轉向兼顧安全性、成本和臨床效率的綜合手術解決方案。

地區

本期內容涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

調查方法附錄與簡稱

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

止血設備市場

• 摘要整理
  • 全球止血器械市場概覽
  • 競爭分析
  • 流程分段
  • 市場區隔
  • 目標區域
• 介紹
• 手術次數
• 市場概覽
  • 按區隔市場
  • 按地區
• 市場分析與預測
  • 止血探針市場
  • 結紮裝置市場
  • 硬化療法針市場
  • 止血粉市場
• 推動和阻礙因素
• 競爭市佔率分析

簡稱

The global hemostasis device market was valued at approximately $716 million in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 4.0 percent, reaching nearly $945 million by 2032.

This report covers hemostasis probes, ligation devices, sclerotherapy needles, and hemostasis powders, which together form the complete global hemostasis device market. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report includes historical data from 2022 to 2024 and forecasts through 2032.

The scope reflects how hospitals and endoscopy centers evaluate product performance, combination therapies, and device innovation to improve outcomes and manage gastrointestinal bleeding effectively.

Market Overview

Hemostasis devices are used during gastrointestinal procedures to control and prevent bleeding. They include hemostasis probes, ligation clips and bands, sclerotherapy needles, and hemostasis powders. Collectively, these devices are essential for treating acute bleeding conditions, preventing post-procedure complications, and reducing the need for surgical intervention.

The global market continues to expand as patient demographics and procedural trends shift. The aging population, coupled with the increasing prevalence of diseases such as cirrhosis, hepatitis, and peptic ulcers, is driving demand for hemostatic interventions. As the incidence of gastrointestinal bleeding grows, healthcare providers are adopting a broader range of hemostatic solutions to improve safety and reduce procedure times.

One of the most significant developments influencing this market is the growing use of combination therapies. Studies have shown that procedures combining sclerotherapy needles with ligation clips or electrosurgical probes yield higher success rates and reduce the need for repeat interventions. Because both physicians and patients seek greater procedural efficiency and lower recurrence, adoption of these combination approaches continues to increase.

While pricing pressure and procurement dynamics continue to challenge manufacturers, rising procedure volumes, broader global access, and continuous technological improvement are expected to sustain long-term growth through 2032.

Market Drivers

Combination Therapy

Combination therapies that pair sclerotherapy needles with other hemostasis devices, such as ligation clips or electrosurgical probes, have been shown to be more effective than single-device procedures. By improving hemostatic success and reducing the need for follow-up treatments, these techniques support greater physician confidence and better patient outcomes.

This approach not only increases clinical adoption but also raises unit consumption per procedure. As hospitals move toward evidence-based care models, the preference for multi-device solutions will continue to drive unit sales growth.

Ligation Clips

The ligation clip segment is showing steady growth as more physicians prefer clips over ligation bands for the management of bleeding and the closure of mucosal defects. Clips are typically used in multiples per procedure, which raises total unit volumes. In addition, clip products command a price premium compared to bands, enhancing market value growth.

Ongoing product innovation in clip design and deployment systems has further strengthened this segment. Devices that provide better precision, rotation control, and deployment reliability are improving clinical efficiency and user confidence.

Demographic Factors

Population aging remains one of the strongest macroeconomic drivers in the hemostasis device market. Older adults experience higher rates of gastrointestinal bleeding caused by chronic liver disease, variceal conditions, and comorbidities that increase bleeding risk.

At the same time, unhealthy lifestyle trends-such as poor diet, alcohol consumption, and non-steroidal anti-inflammatory drug use-are contributing to rising cases of GI bleeding even among younger populations. The combined impact of these demographic and behavioral factors is expected to keep procedural demand high and sustain market expansion through 2032.

Growing Endoscopic Capabilities

As endoscopic technologies advance, physicians can manage a wider range of bleeding conditions without surgery. Modern endoscopy systems enable precise visualization of bleeding sites, while improved electrosurgical energy control supports faster coagulation. These capabilities increase the procedural success rate and drive higher utilization of hemostasis products across hospitals and ambulatory centers.

Market Limiters

Group Purchasing Organizations (GPOs)

Group purchasing organizations represent a major procurement channel for hospital equipment but also act as a restraint on market growth. GPOs consolidate demand and negotiate bulk pricing, which restricts manufacturers' ability to maintain higher ASPs.

They also limit hospitals' access to newer or niche products by focusing on standardized purchasing contracts. Vendors that depend heavily on GPO contracts may face slower price realization and reduced flexibility to expand their product portfolios within contracted facilities.

Drug Treatment Alternatives

Pharmaceutical companies continue to develop medications designed to prevent unexpected gastrointestinal bleeding. These therapies, particularly those targeting anticoagulant reversal or ulcer protection, may reduce the incidence of bleeding that requires procedural intervention.

If these drug therapies gain widespread adoption, they could reduce procedural volumes and slow demand for mechanical and electrosurgical hemostasis devices in certain cases.

Market Cannibalization

Within the broader hemostasis market, competition among device types limits overall value growth. For instance, ligation clips-though expanding rapidly-are capturing share from electrosurgical probes, heat probes, and argon plasma coagulation probes.

While these devices can be used in combination with clips, they are most effective when paired with sclerotherapy needles. As product preferences evolve, growth in one category can come at the expense of others, resulting in internal market shifts rather than net expansion.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.

Qualitative Coverage

Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that influence hemostasis device demand.

Time Frame

Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.

Data Sources

Primary interviews with endoscopists, purchasing managers, and industry executives; hospital procurement and regulatory databases; import and export data; and the iData Research internal database.

Method Note

Revenue estimates are modeled from units multiplied by ASP, validated with procedure volumes and utilization assumptions for each device type.

Markets Covered and Segmentation

• Hemostasis Device Market - Further Segmented Into:

Hemostasis Probe

Ligation Device

Sclerotherapy Needle

Hemostasis Powder

Competitive Analysis

Boston Scientific was the global leader in the hemostasis device market in 2025, maintaining strong positions across all major segments. The company's leadership in the ligation clip market was reinforced by the launch of the Resolution 360(TM) in 2016 and the upgraded Resolution 360(TM) ULTRA in 2020. Boston Scientific also markets the Gold Probe(TM) line as its flagship hemostasis probe, widely recognized for consistent performance and reliability.

Olympus Corporation ranked second in the market, supported by its broad product portfolio and long-standing expertise in gastrointestinal endoscopy. The company's leadership in the ligation device segment anchors its competitive strength. Olympus also remains the sole supplier in the heat probe market, with its HeatProbes(TM) product line used globally for endoscopic thermal coagulation.

Cook Medical held the third-largest share of the hemostasis device market. Its portfolio is led by the 6 Shooter(R) Universal Saeed(R) Multi-Ligator, which is widely used in endoscopic ligation procedures. The company also maintains a presence in ligation clips, electrosurgical probes, and sclerotherapy needles, ensuring a comprehensive offering across multiple endoscopic applications.

This competitive landscape is moderately concentrated, with the top three companies accounting for the majority of total market value. Regional competitors participate primarily in cost-sensitive markets, where pricing flexibility and local distribution relationships provide an advantage.

Technology and Practice Trends

Combination treatment protocols are becoming the standard approach for managing gastrointestinal bleeding, improving success rates and reducing rebleeding risk.

Single-use device adoption is increasing, particularly in hospitals focused on infection control and workflow efficiency.

Refinements in clip and probe design are improving procedural accuracy, rotation control, and deployment consistency.

Energy-based hemostasis technologies, including heat probes and argon plasma coagulation, remain key tools in conjunction with mechanical devices.

Training expansion and guideline alignment are enhancing physician familiarity with multi-device hemostasis procedures.

Powder-based hemostatic agents are gaining interest as adjunct tools for diffuse or difficult-to-access bleeding sites.

Together, these trends illustrate the market's shift toward integrated procedural solutions that balance safety, cost, and clinical efficiency.

Geography

This edition covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global hemostasis device market

How are combination therapies and ligation clip adoption influencing market value

What factors are driving procedure volume growth in aging populations

How are drug treatments, GPO contracts, and internal device competition shaping pricing and share

Which manufacturers-Boston Scientific, Olympus, and Cook Medical-lead the market, and how are they differentiating their portfolios

What technological and procedural trends are expected to define next-generation hemostasis solutions

The Global Hemostasis Device Market Report from iData Research answers these questions with detailed procedure-based models, company share analysis, and pricing insights. Use it to plan product strategy, evaluate growth opportunities, and guide commercial and R&D decision-making.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Hemostasis Device Market

• 11.1 Executive Summary
  • 11.1.1 Global Hemostasis Device Market Overview
  • 11.1.2 Competitive Analysis
  • 11.1.3 Procedure Segmentation
  • 11.1.4 Market Segmentation
  • 11.1.5 Regions Included
• 11.2 Introduction
• 11.3 Procedure Numbers
• 11.4 Market Overview
  • 11.4.1 By Segment
  • 11.4.2 By Region
• 11.5 Market Analysis And Forecast
  • 11.5.1 Hemostasis Probe Market
    • 11.5.1.1 Electrosurgical Probe Market
    • 11.5.1.2 Heat Probe Market
    • 11.5.1.3 Argon Probe Market
  • 11.5.2 Ligation Device Market
    • 11.5.2.1 Ligation Band Market
    • 11.5.2.2 Ligation Clip Market
  • 11.5.3 Sclerotherapy Needle Market
  • 11.5.4 Hemostasis Powder Market
• 11.6 Drivers And Limiters
  • 11.6.1 Market Drivers
  • 11.6.2 Market Limiters
• 11.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 11-1: Hemostasis Device Market, Global, 2025 & 2032
• Chart 11-2: Hemostasis Device Procedures, Global, 2025
• Chart 11-3: Hemostasis Procedures by Region, Global, 2022 - 2032
• Chart 11-4: Hemostasis Device Market by Segment, Global, 2022 - 2032
• Chart 11-5: Hemostasis Device Market by Region, Global, 2022 - 2032
• Chart 11-6: Leading Competitors, Hemostasis Device Market, Global, 2025

LIST OF FIGURES

• Figure 11-1: Hemostasis Device Procedure Segmentation
• Figure 11-2: Hemostasis Device Market Segmentation
• Figure 11-3: Hemostasis Device Regions Covered, Global (1 of 2)
• Figure 11-4: Hemostasis Device Regions Covered, Global (2 of 2)
• Figure 11-5: Hemostasis Procedures by Region, Global, 2022 - 2032
• Figure 11-6: Hemostasis Procedures by Country, North America, 2022 - 2032
• Figure 11-7: Hemostasis Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 11-8: Hemostasis Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 11-9: Hemostasis Procedures by Country, Western Europe, 2022 - 2032
• Figure 11-10: Hemostasis Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 11-11: Hemostasis Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 11-12: Hemostasis Procedures by Country, Middle East, 2022 - 2032
• Figure 11-13: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 11-14: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 11-15: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 11-16: Hemostasis Procedures by Country, Africa, 2022 - 2032
• Figure 11-17: Hemostasis Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 11-18: Hemostasis Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 11-19: Hemostasis Probe Market by Segment, Global, 2022 - 2031 (US$M)
• Figure 11-20: Total Hemostasis Probe Market, Global, 2022 - 2032
• Figure 11-21: Units Sold by Region, Hemostasis Probe Market, Global, 2022 - 2032
• Figure 11-22: Average Selling Price by Region, Hemostasis Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-23: Market Value by Region, Hemostasis Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-24: Electrosurgical Probe Market, Global, 2022 - 2032
• Figure 11-25: Units Sold by Region, Electrosurgical Probe Market, Global, 2022 - 2032
• Figure 11-26: Average Selling Price by Region, Electrosurgical Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-27: Market Value by Region, Electrosurgical Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-28: Heat Probe Market, Global, 2022 - 2032
• Figure 11-29: Units Sold by Region, Heat Probe Market, Global, 2022- 2032
• Figure 11-30: Average Selling Price by Region, Heat Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-31: Market Value by Region, Heat Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-32: Argon Probe Market, Global, 2022 - 2032
• Figure 11-33: Units Sold by Region, Argon Probe Market, Global, 2022 - 2032
• Figure 11-34: Average Selling Price by Region, Argon Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-35: Market Value by Region, Argon Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-36: Ligation Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 11-37: Total Ligation Device Market, Global, 2022 - 2032
• Figure 11-38: Units Sold by Region, Ligation Device Market, Global, 2022 - 2032
• Figure 11-39: Average Selling Price by Region, Ligation Device Market, Global, 2022 - 2032 (US$)
• Figure 11-40: Market Value by Region, Ligation Device Market, Global, 2022 - 2032 (US$M)
• Figure 11-41: Ligation Band Market, Global, 2022 - 2032
• Figure 11-42: Units Sold by Region, Ligation Band Market, Global, 2022 - 2032
• Figure 11-43: Average Selling Price by Region, Ligation Band Market, Global, 2022 - 2032 (US$)
• Figure 11-44: Market Value by Region, Ligation Band Market, Global, 2022 - 2032 (US$M)
• Figure 11-45: Ligation Clip Market, Global, 2022 - 2032
• Figure 11-46: Units Sold by Region, Ligation Clip Market, Global, 2022 - 2032
• Figure 11-47: Average Selling Price by Region, Ligation Clip Market, Global, 2022 - 2032 (US$)
• Figure 11-48: Market Value by Region, Ligation Clip Market, Global, 2022 - 2032 (US$M)
• Figure 11-49: Sclerotherapy Needle Market, Global, 2022 - 2032
• Figure 11-50: Units Sold by Region, Sclerotherapy Needle Market, Global, 2022 - 2032
• Figure 11-51: Average Selling Price by Region, Sclerotherapy Needle Market, Global, 2022 - 2032 (US$)
• Figure 11-52: Market Value by Region, Sclerotherapy Needle Market, Global, 2022 - 2032 (US$M)
• Figure 11-53: Hemostasis Powder Market, Global, 2022 - 2032
• Figure 11-54: Units Sold by Region, Hemostasis Powder Market, Global, 2022 - 2032
• Figure 11-55: Average Selling Price by Region, Hemostasis Powder Market, Global, 2022 - 2032 (US$)
• Figure 11-56: Market Value by Region, Hemostasis Powder Market, Global, 2022 - 2032 (US$M)
• Figure 11-57: Leading Competitors, Hemostasis Device Market, Global, 2025